At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 10 enrolled
Drug / intervention
Atropine sulfate gel (0.01%)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single-Dose Pharmacokinetics of Atropine Oral Gel in Healthy Adults
In Brief
A Early Phase 1 clinical trial evaluating Atropine sulfate gel (0.01%) for Cerebral Palsy and Sialorrhea. Completed, enrolled 10 participants across 1 site.
Detailed Summary
To evaluate the single-dose pharmacokinetics of atropine gel formulation after topical administration in the oral cavity of healthy adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy, Sialorrhea
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
20222023202420252026
First PostedDec 2021
Enrollment StartOct 2022
Primary CompletionJun 2023
Study CompletionDec 2024
TodayJul 2026
First PostedDec 20, 2021
Enrollment StartOct 1, 2022
Primary CompletionJun 30, 2023
Study CompletionDec 10, 2024
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.5 years ago
Interventions
Atropine sulfate gel (0.01%)drug
A research nurse will measure 1 gram of gel using a calibrated measuring spoon and will provide it to the participant for self-administration.